Pre-Market Stock Notes (JAN 23, 2007)
(AAPL) Apple’s Steve Jobs has been questioned by the SEC regarding stock options; stock down 1%.(ADTN) Adtran $0.26 EPS vs $0.23e.(ALU) Alcatel-Lucent trading down 10% on earnings warning; same conglomerates, same old story.(AV) Avaya $0.13 EPS vs $0.13e.(AVAV) AeroVironment priced…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
(AAPL) Apple’s Steve Jobs has been questioned by the SEC regarding stock options; stock down 1%.
(ADTN) Adtran $0.26 EPS vs $0.23e.
(ALU) Alcatel-Lucent trading down 10% on earnings warning; same conglomerates, same old story.
(AV) Avaya $0.13 EPS vs $0.13e.
(AVAV) AeroVironment priced its IPO at $17.00 per share; above the range.
(BAC) Bank of America $1.19 EPS vs $1.18e.
(BLK) Blackrock $1.61 EPS vs $1.54e.
(CHINA) CDC Corp up 2% on Korean distribution pact.
(COH) Coach trading up 3% on beating expectations at $0.61 EPS vs $0.58e..
(CSX) CSX $0.57 EPS vs $0.57e; that is before an $0.18 gain.
(DD) DuPont $0.45 EPS as expected; guidance in line.
(DHI) DRHorton $0.35 EPS vs $0.33e.
(EMC) EMC trading up 1.7% after meeting and keeping strong guidance.
(JNJ) J&J $0.81 EPS vs $0.79e.
(FDRY) Foundry taking $185 million or more in charges related to past options.
(GPS) Gap rose almost 3%after Paul Pressler stepped down; stock up 2.6%.
(IIVI) II-VI $0.30 EPS vs $0.28e.
(JCG) J.Crew reaffirmed guidance for 2006 & comfortable with 2007.
(MAIR) MAIR Holdings (Mesaba Air) up 2% on Northwest Air agreement.
(NBIX) Neurocrine Bio traded up almost 10% after pushing up Indiplon refilling with FDA after having resolved certain conditions.
(QTWW) Quantum Fuel in hydrogen fuel injection pact with Ford for its shuttle bus program; stock up 9%.
(ROCK) Gibralter Steel lowered guidance.
(TGT) Target maintained +3.5% to 5.5% s-s-s growth for January.
(TIN) Temple-Inland trading up 6% after Icahn disclosed stake.
(TLAB) Tellabs $0.10 EPS vs $0.09e.
(TXN) Texas Instruments traded up 3%after meeting estimates, even though guidance was light.
(UTX) United Tech $0.87 EPS vs $0.85e; reaffirmed guidance.
(VPHM) ViroPharma will replace PSTI on S&P Small Cap 600 Index after January 25 close.
(WB) Wachovia $1.21 EPS vs $1.18e.
(XRX) Xerox $0.38 EPS vs $0.37e.
Contact [email protected] for any questions or corrections.
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.